Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels.

ApoE, apolipoprotein E CEUMI, contrast-enhanced ultrasound molecular imaging CVD, cardiovascular disease GLP, glucagon-like peptide GLP-1R, glucagon-like peptide-1 receptor GLP-1RA, glucagon-like peptide-1 receptor agonist HDL-C, high-density lipoprotein cholesterol HbA1c, glycated hemoglobin ICAM, intercellular cell adhesion molecule IL, interleukin LDL-C, low-density lipoprotein cholesterol MB, microbubble MBCtr, control microbubbles MBVCAM-1, microbubbles targeted to VCAM MCP, monocyte chemoattractant protein OPN, osteopontin TG, triglycerides TGRL, triglyceride-rich lipoproteins TNF, tumor necrosis factor VCAM, vascular cell adhesion molecule VLDL-C, very low-density lipoprotein cholesterol atherosclerosis liraglutide molecular imaging ultrasound

Journal

JACC. Basic to translational science
ISSN: 2452-302X
Titre abrégé: JACC Basic Transl Sci
Pays: United States
ID NLM: 101677259

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 14 03 2022
revised: 02 08 2022
accepted: 02 08 2022
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

The authors determined the effect of the GLP-1 receptor agonist liraglutide on endothelial surface expression of vascular cell adhesion molecule (VCAM)-1 in murine apolipoprotein E knockout atherosclerosis. Contrast-enhanced ultrasound molecular imaging using microbubbles targeted to VCAM-1 and control microbubbles showed a 3-fold increase in endothelial surface VCAM-1 signal in vehicle-treated animals, whereas in the liraglutide-treated animals the signal ratio remained around 1 throughout the study. Liraglutide had no influence on low-density lipoprotein cholesterol or glycated hemoglobin, but reduced TNF-α, IL-1β, MCP-1, and OPN. Aortic plaque lesion area and luminal VCAM-1 expression on immunohistology were reduced under liraglutide treatment.

Identifiants

pubmed: 36908664
doi: 10.1016/j.jacbts.2022.08.002
pii: S2452-302X(22)00302-3
pmc: PMC9998474
doi:

Types de publication

Journal Article

Langues

eng

Pagination

189-200

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

This work is supported by grants 310030-169905 and 310030-197673 from the Swiss national Science Foundation and from the Swiss Heart Foundation to Dr Kaufmann. This work was funded in part by Novo Nordisk A/S, Bagsværd, Denmark. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

Cardiovasc Diabetol. 2018 Apr 10;17(1):53
pubmed: 29636047
Cell Metab. 2016 Jul 12;24(1):15-30
pubmed: 27345422
Circ Res. 2000 Jul 21;87(2):153-9
pubmed: 10904000
J Endocrinol. 2009 Apr;201(1):59-66
pubmed: 19136619
Cytokine Growth Factor Rev. 2015 Dec;26(6):673-85
pubmed: 26005197
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
J Clin Invest. 2020 Mar 2;130(3):1392-1404
pubmed: 31985487
J Clin Invest. 2001 May;107(10):1255-62
pubmed: 11375415
Circ Res. 2012 Sep 28;111(8):1054-64
pubmed: 22874466
Circulation. 2003 Feb 11;107(5):679-81
pubmed: 12578867
Nature. 1998 Aug 27;394(6696):894-7
pubmed: 9732872
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):145-158
pubmed: 31747801
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2187-92
pubmed: 23908248
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Diab Vasc Dis Res. 2013 Jul;10(4):353-60
pubmed: 23673376
JACC Basic Transl Sci. 2018 Nov 21;3(6):844-857
pubmed: 30623143
Atherosclerosis. 1999 Mar;143(1):205-11
pubmed: 10208497
Diab Vasc Dis Res. 2011 Apr;8(2):117-24
pubmed: 21562063
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):54-9
pubmed: 19834105
Diabetes Care. 2020 Jul;43(7):1546-1552
pubmed: 32366578
Front Endocrinol (Lausanne). 2021 Nov 30;12:790405
pubmed: 34917038
Thromb Res. 2011 Aug;128(2):117-23
pubmed: 21636112
Circulation. 2008 May 6;117(18):2340-50
pubmed: 18427132
Neurobiol Dis. 2007 Dec;28(3):276-85
pubmed: 17804249
P T. 2010 Sep;35(9):498-529
pubmed: 20975808
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E895-E907
pubmed: 30860874
Circulation. 2007 Jul 17;116(3):276-84
pubmed: 17592078
Front Pharmacol. 2022 Apr 13;13:786767
pubmed: 35496307
Curr Diab Rep. 2012 Jun;12(3):280-5
pubmed: 22492060
J Am Soc Echocardiogr. 2021 Apr;34(4):433-442.e3
pubmed: 33253812
PLoS One. 2014 Jan 29;9(1):e86642
pubmed: 24489757
PLoS One. 2013;8(3):e58761
pubmed: 23554922
Endocrinology. 2014 Apr;155(4):1280-90
pubmed: 24467746

Auteurs

Mukesh Punjabi (M)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Alexandra Kosareva (A)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Lifen Xu (L)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Amanda Ochoa-Espinosa (A)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Sarah Decembrini (S)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Georg Hofmann (G)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Samira Wyttenbach (S)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.

Bidda Rolin (B)

Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.

Michael Nyberg (M)

Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.

Beat A Kaufmann (BA)

Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Cardiology, University Hospital and University of Basel, Basel, Switzerland.

Classifications MeSH